Investments
25Portfolio Exits
9Partners & Customers
10Service Providers
1About Takeda Pharmaceutical
Takeda Pharmaceutical (TYO: 4502) (NYSE: TAK) is a research-based, global pharmaceutical company. Takeda is committed to striving toward better health for patients worldwide through innovation in medicine.
Takeda Pharmaceutical Headquarter Location
2-1-1 Nihonbashihonmachi, Chuo-ku
Tokyo, 103-8668,
Japan
+81 (0)3 3278 2111
Expert Collections containing Takeda Pharmaceutical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Takeda Pharmaceutical in 3 Expert Collections, including Poop Tech.
Poop Tech
114 items
Pharma Startups
5,090 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Rare Diseases
25 items
Takeda Pharmaceutical Web Traffic
Takeda Pharmaceutical Rank
Research containing Takeda Pharmaceutical
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Takeda Pharmaceutical in 2 CB Insights research briefs, most recently on Apr 19, 2021.
Latest Takeda Pharmaceutical News
Oct 14, 2021
Oct. 13, 2021 In its first big pharma deal since it was founded around a cell programming technology in 2009, Immusoft Corp. signed Takeda Pharmaceutical Co. Ltd. to a research collaboration and license option targeting rare inherited metabolic disorders. The agreement brings an undisclosed up-front fee and research funding to Immusoft, which is also eligible to earn more than $900 million if all options are exercised and all milestones hit.
Takeda Pharmaceutical Investments
25 Investments
Takeda Pharmaceutical has made 25 investments. Their latest investment was in Adaptate Biotherapeutics as part of their Series A on April 4, 2021.
Takeda Pharmaceutical Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/20/2021 | Series A | Adaptate Biotherapeutics | $18M | Yes | 2 | |
4/1/2021 | Seed VC | Orizuru Therapeutics | $9.07M | Yes | 4 | |
10/6/2020 | Seed VC | xFOREST Therapeutics | Yes | 2 | ||
6/25/2020 | Series E | |||||
5/20/2020 | Series C - IV |
Date | 4/20/2021 | 4/1/2021 | 10/6/2020 | 6/25/2020 | 5/20/2020 |
|---|---|---|---|---|---|
Round | Series A | Seed VC | Seed VC | Series E | Series C - IV |
Company | Adaptate Biotherapeutics | Orizuru Therapeutics | xFOREST Therapeutics | ||
Amount | $18M | $9.07M | |||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 4 | 2 |
Takeda Pharmaceutical Portfolio Exits
9 Portfolio Exits
Takeda Pharmaceutical has 9 portfolio exits. Their latest portfolio exit was AmWell on September 17, 2020.
Takeda Pharmaceutical Acquisitions
22 Acquisitions
Takeda Pharmaceutical acquired 22 companies. Their latest acquisition was HilleVax on July 31, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
7/31/2021 | Spinoff / Spinout | $135M | Spinoff / Spinout | 1 | ||
3/9/2021 | Partnership | $56M | Acquired | 9 | ||
4/16/2020 | Acquired | 1 | ||||
2/26/2020 | Corporate Minority | |||||
4/25/2018 |
Date | 7/31/2021 | 3/9/2021 | 4/16/2020 | 2/26/2020 | 4/25/2018 |
|---|---|---|---|---|---|
Investment Stage | Spinoff / Spinout | Partnership | Corporate Minority | ||
Companies | |||||
Valuation | |||||
Total Funding | $135M | $56M | |||
Note | Spinoff / Spinout | Acquired | Acquired | ||
Sources | 1 | 9 | 1 |
Takeda Pharmaceutical Partners & Customers
10 Partners and customers
Takeda Pharmaceutical has 10 strategic partners and customers. Takeda Pharmaceutical recently partnered with World Food Programme on September 9, 2021.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
9/22/2021 | Partner | World Food Programme | Italy | WFP and Takeda deepen partnership in West Africa to strengthen health emergency response WFP and Takeda Pharmaceutical Company Limited deepen partnership in West Africa to strengthen health emergency response . | 1 |
9/8/2021 | Licensor | Novavax | United States | Takeda to deliver Novavax’s Covid-19 vaccine doses to Japan In August last year , Takeda Pharmaceutical entered a partnership with Novavax to develop , produce and market the latter 's covid‑19 vaccine candidate in Japan . | 1 |
8/23/2021 | Licensor | Genevant | United States | This is the second collaboration between Genevant Sciences Corporation and Takeda Pharmaceutical Company Limited , following an earlier 2021 agreement to develop nucleic acid therapeutics directed to specified targets in hepatic stellate cells to treat liver fibrosis . | 4 |
8/10/2021 | Licensor | ||||
7/30/2021 | Licensee |
Date | 9/22/2021 | 9/8/2021 | 8/23/2021 | 8/10/2021 | 7/30/2021 |
|---|---|---|---|---|---|
Type | Partner | Licensor | Licensor | Licensor | Licensee |
Business Partner | World Food Programme | Novavax | Genevant | ||
Country | Italy | United States | United States | ||
News Snippet | WFP and Takeda deepen partnership in West Africa to strengthen health emergency response WFP and Takeda Pharmaceutical Company Limited deepen partnership in West Africa to strengthen health emergency response . | Takeda to deliver Novavax’s Covid-19 vaccine doses to Japan In August last year , Takeda Pharmaceutical entered a partnership with Novavax to develop , produce and market the latter 's covid‑19 vaccine candidate in Japan . | This is the second collaboration between Genevant Sciences Corporation and Takeda Pharmaceutical Company Limited , following an earlier 2021 agreement to develop nucleic acid therapeutics directed to specified targets in hepatic stellate cells to treat liver fibrosis . | ||
Sources | 1 | 1 | 4 |
Takeda Pharmaceutical Service Providers
1 Service Provider
Takeda Pharmaceutical has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Acq - P2P | Investment Bank | Financial Advisor |
Service Provider | |
|---|---|
Associated Rounds | Acq - P2P |
Provider Type | Investment Bank |
Service Type | Financial Advisor |
Partnership data by VentureSource
Takeda Pharmaceutical Team
20 Team Members
Takeda Pharmaceutical has 20 team members, including current Chief Executive Officer, President, Yasuchika Hasegawa.
Name | Work History | Title | Status |
|---|---|---|---|
Yasuchika Hasegawa | Chief Executive Officer, President | Current | |
Frank Morich | Chief Executive Officer | Current | |
Jeremy G Chadwick | Senior Vice President | Current | |
Daniel Curran | Senior Vice President | Current | |
Thom K. | dRx Capital, Cambia Health Solutions, Northwestern Medicine, and Adams Street Partners | Investment Partner | Current |
Name | Yasuchika Hasegawa | Frank Morich | Jeremy G Chadwick | Daniel Curran | Thom K. |
|---|---|---|---|---|---|
Work History | dRx Capital, Cambia Health Solutions, Northwestern Medicine, and Adams Street Partners | ||||
Title | Chief Executive Officer, President | Chief Executive Officer | Senior Vice President | Senior Vice President | Investment Partner |
Status | Current | Current | Current | Current | Current |